
Brecita 50 Tablet
Marketer
Natco Pharma Ltd
Salt Composition
Brivaracetam (50mg)
Overview Brecita 50 Tablet
Epileptic seizures are managed with the anticonvulsant medication, Brecita 50mg tablets. This medication can be administered independently or in conjunction with other therapies. Continued use is crucial for ongoing seizure prevention. Brecita 50mg tablets regulate abnormal brain electrical activity. Consistent daily dosing, with or without food, is recommended for optimal efficacy. Dosage frequency is determined by your physician to effectively control seizures and may be adjusted gradually. Long-term use is typically advised; discontinue only under your doctor’s guidance. Interrupting treatment or missing doses increases seizure risk. Abrupt cessation may worsen seizures; therefore, always follow your doctor's instructions. Common side effects include nausea, vomiting, headaches, and dizziness. Behavioral changes such as irritability, aggression, or agitation may also occur. These are more frequent initially and usually subside. While most side effects are mild, some require medical attention. Suicidal ideation has been reported in a small percentage of users. Report any mood deterioration to your physician immediately. Prior to commencing treatment, inform your doctor of any pre-existing liver or kidney conditions, depressive disorders, suicidal tendencies, or pregnancy (or pregnancy plans). Nursing mothers should also seek medical counsel before use.
Primary Ingredients of Brecita 50 Tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of Brecita 50 Tablet
Convulsive disorders
Major Benefits of Brecita 50 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Brecita 50mg tablets can be consumed with or without food, however, consistent timing is recommended.
Common Side effects of Brecita 50 Tablet:
- Behavioral changes
- Agitation
- Aggressive behavior
- Dizziness
- Sedation
- Drowsiness
- Neuropsychiatric symptoms
How to use Brecita 50 Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Brecita 50 Tablet can be consumed with or without food, although consistent timing is recommended.
How Brecita 50 Tablet works:
Brecita 50mg tablets are used to treat epilepsy. Their mechanism involves binding to SV2A receptors located on neuronal membranes. This action reduces excessive neuronal firing in the brain, thus inhibiting the propagation of seizure-inducing electrical impulses.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Brecita 50 Tablet is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Use of Brecita 50 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on Brecita 50 Tablet use while breastfeeding is lacking. Seek your physician's advice.
DrivingUNSAFE
Taking Brecita 50 Tablet might cause drowsiness, blurred vision, or dizziness, reducing alertness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
Brecita 50 Tablet is considered safe for individuals with kidney impairment; dosage modification is unnecessary. However, its use is not advised in cases of end-stage renal disease, given the absence of supporting clinical trial evidence.
LiverCAUTION
Patients with liver impairment should use Brecita 50mg tablets cautiously, as dose modification may be necessary. Physician consultation is advised.
What if you forget to take Brecita 50 Tablet :
NA
Facts to Know About Brecita 50 Tablet
| Label | Value |
|---|---|
| Chemical Type | Levetiracetam Analog |
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
| Action Class | Protein ligand AED: Synaptic vesicle 2 |
